Ensifentrine inh 3 mg
Full descriptor
Ensifentrine, inhalation suspension, fda approved final product, non-compounded, administered through dme, unit dose form, 3 mg
Details
- Code
- J7601
- Short descriptor
- Ensifentrine inh 3 mg
- Code set
- HCPCS Level II
- Release
- July 2026
- Status
- Active
- Added
- Jan 1 2025
Nearby codes
Code sets are published in blocks, so neighbours are usually related.
Immunosuppressive drug noc
Acetylcysteine comp unit
Arformoterol non-comp unit
Formoterol fumarate, inh
Levalbuterol comp con
Acetylcysteine non-comp unit
Albuterol comp unit
Albuterol comp con
Sources
- CMS HCPCS Level II — July 2026, public domain
Reference information only. Not billing advice. Verify against the payer before you file.